Pliant Therapeutics Receives FDA Fast Track Designation for PLN-101095 in Combination with Pembrolizumab for the Treatment of ICI-Refractory Solid Tumors
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
| (NASDAQ: PLRX) | Delayed: 0.89 -0.02 (2.2%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.91 | 52 Week High | $ | |||
| Open | $0.93 | 52 Week Low | $ | |||
| Day High | $0.93 | P/E | N/A | |||
| Day Low | $0.88 | EPS | $ | |||
| Volume | 340,622 | |||||
